Angelalign reported $161.4 million in revenue and a 47.7% increase in global case volume in the first half of 2025, driven by international market growth.
Angelalign Technology Inc reported $161.4 million in revenue for the first half of 2025, a 33.1% increase compared to the same period last year. The company’s global clear aligner case volume rose 47.7% year-over-year to approximately 225,800 cases. Adjusted net profit came in at $19.5 million, with gross profit totaling $100.6 million.
Profitability Supported by Operational Efficiency and Cost Control
The company cited growth in case shipments and streamlined operations at its treatment planning centers and manufacturing facilities as key drivers of financial performance. Angelalign also benefited from tighter expense controls during the period, including a delay in hiring and in launching certain facilities outside of Mainland China, in response to global trade uncertainties.
Focus on International Expansion
Angelalign continued to scale its international operations in the first half of the year. Case volume outside of Mainland China increased 103.5% to 117,200 cases. The company attributed this growth to broader market penetration, improved delivery capabilities, and expanded clinical education programs.
Steady Growth in Domestic Market
In Mainland China, Angelalign reported 108,600 cases, a 14% increase from the same period last year. The company maintained its focus on early orthodontic treatment and identified emerging markets as long-term growth opportunities.
Product Development and Research Initiatives
The company introduced new solutions targeting early orthodontic treatment and complex cases. It also incorporated digital tools such as intelligent consultations and treatment monitoring into its offerings. Angelalign collaborated with several universities during the reporting period to advance clinical research.
Expansion of Manufacturing and Planning Capacity
To meet increasing demand, Angelalign is developing a global manufacturing network. Its treatment planning centers in Brazil and Southeast Asia are already supporting operations in the United States. The company said it plans to continue building facilities in additional locations to ensure consistent delivery times.
Investment in Data Security and IP Protection
Angelalign reported ongoing investments in its data security systems and compliance processes to align with local regulations. The company also continued to focus on strengthening its legal capabilities to support its intellectual property strategy.
“We remain confident in the long-term growth prospects of the global clear aligner industry,” said CEO Fox Hu. “Key priorities include scaling production of aligners and treatment plans, enhancing clinical capabilities, continuing our history of product innovation with appropriate IP protection, increasing our investments in compliance while driving sustainable growth across all regions.”
Photo: ID 19840738 © Seemitch | Dreamstime.com
